Hereditary cancer genes are highly susceptible to splicing mutations.
Substitutions that disrupt pre-mRNA splicing are a common cause of genetic disease. On average, 13.4% of all hereditary disease alleles are classified as splicing mutations mapping to the canonical 5' and 3' splice sites. However, splicing mutations present in exons and deeper intronic pos...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-03-01
|
| Series: | PLoS Genetics |
| Online Access: | http://europepmc.org/articles/PMC5854443?pdf=render |